Search research articles
Contact Us
Filters
Showing results (91-100 of 114) with videos related to
Page
of 12
Sort By:
Journal of Clinical Pharmacology
|
August 12, 2017
Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects
Chih-Wei Lin, Sandeep Dutta, Bifeng Ding, et al.
Clinical Pharmacology in Drug Development
|
June 9, 2021
Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil
Ashit Trivedi, Rajneet K Oberoi, Mia Mackowski, et al.
Clinical Pharmacology in Drug Development
|
October 11, 2021
Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects
Ashit Trivedi, Winnie Sohn, Cheng-Pang Hsu, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Clinical Safety, Pharmacokinetics, and Pharmacodynamics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 in Healthy Volunteers and Elderly Adults
Wei Liu, David A Katz, Charles Locke, et al.
The AAPS Journal
|
November 25, 2015
Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies
Sven Mensing, Akshanth R Polepally, Denise König, et al.
Journal of Cardiovascular Computed Tomography
|
October 9, 2012
Dual-energy CT and its potential use for quantitative myocardial CT perfusion
Aaron So, Jiang Hsieh, Suresh Narayanan, et al.
British Journal of Clinical Pharmacology
|
September 24, 2016
Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials
Sven Mensing, Doerthe Eckert, Shringi Sharma, et al.
Clinical and Translational Science
|
August 20, 2021
Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model
Ashit Trivedi, Winnie Sohn, Priyanka Kulkarni, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease
Jeffrey F Waring, Qi Tang, Weining Z Robieson, et al.
Biopharmaceutics & Drug Disposition
|
June 4, 2021
Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator
Ashit Trivedi, Rajneet K Oberoi, Mia Mackowski, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 114) with videos related to
Sort By:
Page
of 12
Journal of Clinical Pharmacology
|
August 12, 2017
Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects
Chih-Wei Lin, Sandeep Dutta, Bifeng Ding, et al.
Clinical Pharmacology in Drug Development
|
June 9, 2021
Effect of Varying Degrees of Hepatic Impairment on the Pharmacokinetics of Omecamtiv Mecarbil
Ashit Trivedi, Rajneet K Oberoi, Mia Mackowski, et al.
Clinical Pharmacology in Drug Development
|
October 11, 2021
Pharmacokinetic Drug-Drug Interaction Study of Omecamtiv Mecarbil With Amiodarone and Digoxin in Healthy Subjects
Ashit Trivedi, Winnie Sohn, Cheng-Pang Hsu, et al.
Clinical Pharmacology in Drug Development
|
April 29, 2016
Clinical Safety, Pharmacokinetics, and Pharmacodynamics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 in Healthy Volunteers and Elderly Adults
Wei Liu, David A Katz, Charles Locke, et al.
The AAPS Journal
|
November 25, 2015
Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Patients with Hepatitis C Virus Genotype 1 Infection: Combined Analysis from 9 Phase 1b/2 Studies
Sven Mensing, Akshanth R Polepally, Denise König, et al.
Journal of Cardiovascular Computed Tomography
|
October 9, 2012
Dual-energy CT and its potential use for quantitative myocardial CT perfusion
Aaron So, Jiang Hsieh, Suresh Narayanan, et al.
British Journal of Clinical Pharmacology
|
September 24, 2016
Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials
Sven Mensing, Doerthe Eckert, Shringi Sharma, et al.
Clinical and Translational Science
|
August 20, 2021
Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model
Ashit Trivedi, Winnie Sohn, Priyanka Kulkarni, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease
Jeffrey F Waring, Qi Tang, Weining Z Robieson, et al.
Biopharmaceutics & Drug Disposition
|
June 4, 2021
Switchability and minimal effect of food on pharmacokinetics of modified release tablet strengths of omecamtiv mecarbil, a cardiac myosin activator
Ashit Trivedi, Rajneet K Oberoi, Mia Mackowski, et al.
Page
of 12